Category Archives: "News"

TECFIDERA Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients TECFIDERA Provides Robust and [...]
The FDA approves a generic form of Copaxone
The FDA Approves a Generic form of Copaxone® Thursday, April 16, 2015 The U.S. Food and Drug Administration has approved a generic [...]
People with multiple sclerosis may have trouble recognizing emotions
People with MS may have trouble recognizing emotions -- MS can damage parts of the brain that allow us to recognize emotions in others. [...]
EMA validates marketing authorization application for ZINBRYTA for treatment of multiple sclerosis
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTAâ„¢ (Daclizumab High-Yield Process) for Treatment of [...]
Teva Neuroscience & Access Health team up for special multiple sclerosis awareness show: thursday, 3/5
Teva Neuroscience & Access Health Team Up for Special MS Awareness Show: Thursday, March 5 As Multiple Sclerosis Awareness Week [...]
Multiple sclerosis paroxysmal symptoms confused with seizures due to sudden onset
Multiple sclerosis paroxysmal symptoms can be confused with seizures due to its sudden onset. Paroxysmal symptoms are unique to multiple [...]
How Vitamin D repairs myelin in multiple sclerosis
An international team of researchers have proposed how vitamin D repairs myelin in multiple sclerosis. This finding could lead to [...]
Acorda announces data from first clinical trial of remyelinating antibody in multiple sclerosis
Acorda Announces Safety and Tolerability Data from First Clinical Trial of Remyelinating Antibody in Multiple Sclerosis Phase 1 trial [...]
The latest in multiple sclerosis care & research to be presented at educational conference for healthcare professionals
Registration is Open for the CMSC Annual Meeting in Indianapolis, Indiana (Hackensack, NJ, December 2014). The Consortium of Multiple [...]
First multiple sclerosis patients in the U.S. receive Genzyme’s Lemtrada following FDA approval
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval – Lemtrada now available in the U.S. two weeks post [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM